Prescribing restrictions for triple therapy in COPD
We are pleased to announce that our study, exploring barriers to accessing triple therapy for COPD management in primary care across Europe, was presented at the 12th International Care Respiratory Group (IPCRG) World Conference in Athens. The research looked at the variation in the pharmacological management of COPD due to payer-driven access criteria for triple Read More >
COPD care: different countries, same issues
Chronic Obstructive Pulmonary Disease (COPD) persists as a major global public health issue demanding urgent attention from policymakers. Despite being preventable and treatable, COPD is the third leading cause of death globally* accounting for 3.3 million deaths worldwide. Aquarius Population Health conducted a qualitative research study with 17 clinical experts involved in COPD management from Read More >
Identifying the common barriers to optimal COPD care in Japan, Canada, England, and Germany through Evidenced Care Pathways
